Briotech Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Briotech Inc. - overview
Established
2013
Location
Everett, WA, US
Primary Industry
Biotechnology
About
Based in Washington, US, and founded in 2013 by Cynthia Varela and Dan Terry, Briotech Inc. operates as a biotechnology company that manufactures and sells cleaning and skincare products based on Hypochlorous Acid (HOCl) produced by white blood cells. Briotech USA sells HOCl spray under various brand names like BrioPro, BrioCare, and BrioHome. In March 2024, Briotech Inc.
raised an amount of USD 2 million in venture funding from various investors. Briotech's flagship product, BrioHOCl, develops and offers solutions for infectious diseases and antibiotic resistance. The firm’s products operate as a sanitizer, disinfectant, and virucide, proven to combat a wide spectrum of pathogens, including the SARS-CoV-2 virus. The platform employs Electro-Chemical Activated (ECA) Technology, to produce high-purity Hypochlorous Acid (HOCl) formulations, mimicking the body's natural defense mechanisms in killing pathogens without creating resistance.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.brioglobal.com/
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.